Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Attenuation
100%
Shear Stress
100%
Somatostatin
100%
Small-for-size
100%
Acute Phase
100%
Liver Graft Survival
100%
Treatment Group
57%
Small-for-size Graft
42%
Reperfusion
28%
Portal Hypertension
28%
Endothelin-1 (ET-1)
14%
Gene Expression
14%
Messenger RNA (mRNA)
14%
Protective Effect
14%
Blood Flow
14%
Transplantation
14%
Living Donor Liver Transplantation
14%
Heme oxygenase-1 (HO-1)
14%
Portal Pressure
14%
Graft Injury
14%
Grafting from
14%
Portal Hemodynamics
14%
Ultrastructural Changes
14%
Ultrastructure
14%
Liver Transplantation
14%
Liver Transplantation Model
14%
Grafting Ratio
14%
Orthotopic Liver Transplantation
14%
Liver Function
14%
Novel Therapeutics
14%
Liver Graft Injury
14%
Sinusoid
14%
Treatment Regimen
14%
Hepatic Blood Flow
14%
Hemodynamic Stress
14%
Graft Survival
14%
Total Hepatectomy
14%
Medicine and Dentistry
Liver Graft
100%
Graft Survival
100%
Somatostatin
100%
Treatment Group
57%
Liver Transplantation
42%
Low Drug Dose
28%
Portal Hypertension
28%
Survival Rate
14%
Endothelin 1
14%
Heme Oxygenase 1
14%
Blood Flow
14%
Upregulation
14%
Gene Expression
14%
Portal Venous Pressure
14%
Ultrastructure
14%
Hepatectomy
14%
Liver Function
14%
Hemodynamic Stress
14%
Liver Blood Flow
14%
Sinusoid
14%
Hemodynamic
14%
Messenger RNA
14%
Living Donors
14%
Immunology and Microbiology
Shear Stress
100%
Liver Size
100%
Somatostatin
100%
Graft Size
42%
Liver Transplantation
42%
Low Drug Dose
28%
Reperfusion
28%
Survival Rate
14%
Upregulation
14%
Blood Flow
14%
Gene Expression
14%
Hemodynamic
14%
Portal Vein Blood Pressure
14%
Liver Function
14%
Hemodynamic Stress
14%
Liver Blood Flow
14%
Heme Oxygenase
14%
Endothelin
14%
Pharmacology, Toxicology and Pharmaceutical Science
Somatostatin
100%
Treatment Group
57%
Portal Hypertension
28%
Survival Rate
14%
Endothelin 1
14%
Heme Oxygenase 1
14%
Messenger RNA
14%